Expand MRNS Menu
MRNS MENU

MRNS Latest Press Releases

-- January 15, 2025 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPY, HEES, MRNS on Behalf of Shareholders PRNewswire 2:14 PM

-- January 14, 2025 --

$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of AE, MRNS, SASR, ROIC to Take Action PRNewswire 7:00 PM

-- January 9, 2025 --

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MRNS, RHE, SSY, CTV on Behalf of Shareholders PRNewswire 12:50 PM

-- January 7, 2025 --

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders Globe Newswire 11:44 AM

-- January 6, 2025 --

MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS Business Wire 6:06 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA, LBRDA on Behalf of Shareholders PRNewswire 2:02 PM
Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm Globe Newswire 9:07 AM

-- January 3, 2025 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders PRNewswire 11:31 AM

-- December 31, 2024 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders Globe Newswire 7:35 PM

-- December 30, 2024 --

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Marinus Pharmaceuticals, Inc. - MRNS PRNewswire 5:20 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders PRNewswire 1:37 PM
Shareholder Alert: Ademi LLP Investigates Whether Marinus Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders Business Wire 9:43 AM
MRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Marinus Pharmaceuticals, Inc. Is Fair to Shareholders Business Wire 9:08 AM
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. Business Wire 7:00 AM

-- November 12, 2024 --

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results Business Wire 4:00 PM

-- October 24, 2024 --

Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives Business Wire 8:00 AM

-- October 17, 2024 --

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting Business Wire 7:00 AM

-- October 15, 2024 --

Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY Titration Regimens Business Wire 4:00 PM

-- October 9, 2024 --

Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting Business Wire 7:00 AM

-- October 8, 2024 --

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Business Wire 4:04 PM